Topic

California

A collection of 516 issues

How to Get Ilaris (Canakinumab) Covered by Aetna CVS Health in California: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Ilaris (Canakinumab) Covered by Aetna CVS Health in California Yes, Aetna CVS Health covers Ilaris (canakinumab) in California with prior authorization for FDA-approved indications. For Still's disease and periodic fever syndromes, you'll need specialist documentation of diagnosis, failed conventional therapies, and active disease.
6 min read

Myths vs. Facts: Getting Naglazyme (galsulfase) Covered by UnitedHealthcare in California

Answer Box: Fast Facts for California Patients UnitedHealthcare requires prior authorization for Naglazyme (galsulfase) in California. Success depends on complete diagnostic documentation (enzyme assay + genetic testing), specialist involvement, and baseline functional assessments. If denied, California's Independent Medical Review (IMR) overturns 55-70% of medical necessity denials. First step: Have
5 min read

How to Get iLink® Corneal Cross-Linking Covered by Humana in California: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting iLink® Covered by Humana in California Yes, Humana generally covers iLink® corneal cross-linking for progressive keratoconus when medical necessity criteria are met. The fastest path to approval: 1) Verify your ophthalmologist and facility are in-network, 2) Submit prior authorization with documented progression over 12 months (≥1.0
6 min read

How to Get Eylea and Lucentis Covered by UnitedHealthcare in California: Complete Prior Authorization and Appeal Guide

Quick Answer: UnitedHealthcare requires prior authorization for Eylea (aflibercept) and Lucentis (ranibizumab) in California. Submit requests through the UnitedHealthcare Provider Portal with OCT imaging, visual acuity measurements, and diagnosis documentation. If denied, file an internal appeal within 30 days, then request a California DMHC Independent Medical Review for binding external
5 min read